This week, on the precipice of a historic U.S. election I will start with a brief commentary on making portfolio decisions based on election outcomes.
Back by popular demand we have decided to make our new Case For, Case Against segment a permanent fixture. Our head of income research, Mr. Aaron Dunn will make his highly anticipated first argument facing off against Brennan. In the line of fire is Apple Inc. (AAPL: NASDAQ), the iPhone company which should need no introduction. While the stock sold off this week after its quarterly results included a lack of forward guidance, the consumer tech giant is up 47% this year. We argue both sides of the BUY/SELL argument for the stock.
With a hat tip to Movember and men’s cancer prevention and treatment, this week’s Your Stock, Our Take was sent in from a listener on Profound Medical Corp. (PRN: TSX), a medical technology company developing medical treatments with its core technology used to ablate the prostate gland. We let you know if the share price gains are justifiable based on the underlying cash flow at present.
Stock Talk Podcast Episode 195
Stock Talk Podcast Episode 194
Stock Talk Podcast Episode 193
Stock Talk Podcast Episode 192
Stock Talk Podcast Episode 191
Stock Talk Podcast Episode 190
Stock Talk Podcast Episode 189
Stock Talk Podcast Episode 188
Stock Talk Podcast Episode 187
Stock Talk Podcast Episode 186
Stock Talk Podcast Episode 185
Stock Talk Podcast Episode 184
Stock Talk Podcast Episode 183
Stock Talk Podcast Episode 182
Stock Talk Episode Podcast 181
Stock Talk Podcast Episode 180
Stock Talk Podcast Episode 179
Stock Talk Podcast Episode 178
Stock Talk Podcast Episode 177
Stock Talk Podcast Episode 176
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
U.S Property Podcast
Aligned Money Show
Dubai Property Podcast
The Ramsey Show
The Clark Howard Podcast